290 related articles for article (PubMed ID: 10528825)
1. Evolution of chemotherapy with platinum compounds.
Walker EM; Walker SM
Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
[TBL] [Abstract][Full Text] [Related]
2. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
Muggia FM
Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
[TBL] [Abstract][Full Text] [Related]
3. [Cisplatin (platidiam) and the prospects for using complex platinum compounds in the clinical chemotherapy of malignant tumors].
Gorbunova VA
Vopr Onkol; 1989; 35(3):325-30. PubMed ID: 2705315
[TBL] [Abstract][Full Text] [Related]
4. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
5. Nanocapsules of platinum anticancer drugs: development towards therapeutic use.
Bryde S; de Kroon AI
Future Med Chem; 2009 Nov; 1(8):1467-80. PubMed ID: 21426060
[TBL] [Abstract][Full Text] [Related]
6. The resurgence of platinum-based cancer chemotherapy.
Kelland L
Nat Rev Cancer; 2007 Aug; 7(8):573-84. PubMed ID: 17625587
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
Polyzos A; Kosmas C; Tsavaris N; Toufexi H; Lagadas A; Gogas H; Giannakopoulos K; Kouraklis G; Griniatsos J; Felekouras E; Tsigris C; Nikiteas N; Papadopoulos O; Giannopoulos A
Anticancer Res; 2007; 27(3B):1645-51. PubMed ID: 17595790
[TBL] [Abstract][Full Text] [Related]
8. Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
Hausheer FH; Kanter P; Cao S; Haridas K; Seetharamulu P; Reddy D; Petluru P; Zhao M; Murali D; Saxe JD; Yao S; Martinez N; Zukowski A; Rustum YM
Semin Oncol; 1998 Oct; 25(5):584-99. PubMed ID: 9783598
[TBL] [Abstract][Full Text] [Related]
9. Organo-platinum complexes as antitumor agents (review).
Hill JM; Speer RJ
Anticancer Res; 1982; 2(3):173-86. PubMed ID: 6751211
[TBL] [Abstract][Full Text] [Related]
10. Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies.
Williams JI; Weitman S; Gonzalez CM; Jundt CH; Marty J; Stringer SD; Holroyd KJ; Mclane MP; Chen Q; Zasloff M; Von Hoff DD
Clin Cancer Res; 2001 Mar; 7(3):724-33. PubMed ID: 11297269
[TBL] [Abstract][Full Text] [Related]
11. Platinum-based chemotherapy in metastatic breast cancer: current status.
Decatris MP; Sundar S; O'Byrne KJ
Cancer Treat Rev; 2004 Feb; 30(1):53-81. PubMed ID: 14766126
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: a review.
Ferguson PJ
J Otolaryngol; 1995 Aug; 24(4):242-52. PubMed ID: 8551538
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
14. [Application of metal ions and their complexes in medicine II. Application of platina complexes in the treatment of tumor].
Nagy L; Csintalan G; Kálmán E; Nagy E; Sipos P
Acta Pharm Hung; 2004; 74(4):213-22. PubMed ID: 16316049
[TBL] [Abstract][Full Text] [Related]
15. Antitumor active trans-platinum compounds.
Natile G; Coluccia M
Met Ions Biol Syst; 2004; 42():209-50. PubMed ID: 15206104
[No Abstract] [Full Text] [Related]
16. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic options for cisplatin-ineligible patients with advanced carcinoma of the urothelium.
Vaughn DJ
Cancer Treat Rev; 2008 Jun; 34(4):328-38. PubMed ID: 18262363
[TBL] [Abstract][Full Text] [Related]
18. [Anticancer drugs used in medicine and being in clinical research].
Malinowska K; Modranka R; Kedziora J
Pol Merkur Lekarski; 2007 Sep; 23(135):165-9. PubMed ID: 18080687
[TBL] [Abstract][Full Text] [Related]
19. Organometallic compounds in oncology: implications of novel organotins as antitumor agents.
Alama A; Tasso B; Novelli F; Sparatore F
Drug Discov Today; 2009 May; 14(9-10):500-8. PubMed ID: 19429510
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.
Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
J Clin Oncol; 2004 Oct; 22(19):3852-9. PubMed ID: 15326195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
